Byoung Chul Lee

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Age Related Macular Degeneration

Vascular Endothelial Growth Factor

Diabetic Retinopathy

Patient Reported Outcomes

Top Venues

Ophthalmology and therapy

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Dahea Lee, Dongsu Kim, Donggeon Kim, Jisu Kang, Kiram Lee, Hyunji Lee, Yujin Yoon, Youngin Lee, Nahmju Kim, Byoung Chul Cho, Jihoon Chang, Byoung Chul Lee
Harnessing the Potential of FAP-IL-12mut TMEkine™ for Targeted and Enhanced Anti-tumor Responses. Molecular cancer therapeutics (2024)
Yeri Lee, Donggeon Kim, Philip E D Chung, Minkyeong Lee, Nahmju Kim, Jihoon Chang, Byoung Chul Lee
Pre-Clinical Studies of a Novel Bispecific Fusion Protein Targeting C3b and VEGF in Neovascular and Nonexudative AMD Models. Ophthalmology and therapy 13 (8) (2024)
Yeri Lee, Donggeon Kim, Philip E D Chung, Minkyeong Lee, Nahmju Kim, Jihoon Chang, Byoung Chul Lee
Pre-Clinical Studies of a Novel Bispecific Fusion Protein Targeting C3b and VEGF in Neovascular and Nonexudative AMD Models. Ophthalmology and therapy (2024)
Yeri Lee, Donggeon Kim, Philip E D Chung, Minkyeong Lee, Nahmju Kim, Jihoon Chang, Byoung Chul Lee
Pre-Clinical Studies of a Novel Bispecific Fusion Protein Targeting C3b and VEGF in Neovascular and Nonexudative AMD Models. Ophthalmology and therapy 13 (8) (2024)
Yeri Lee, Donggeon Kim, Philip E D Chung, Minkyeong Lee, Nahmju Kim, Jihoon Chang, Byoung Chul Lee
Pre-Clinical Studies of a Novel Bispecific Fusion Protein Targeting C3b and VEGF in Neovascular and Nonexudative AMD Models. Ophthalmology and therapy 13 (8) (2024)
Yeri Lee, Donggeon Kim, Philip E D Chung, Minkyeong Lee, Nahmju Kim, Jihoon Chang, Byoung Chul Lee
Pre-Clinical Studies of a Novel Bispecific Fusion Protein Targeting C3b and VEGF in Neovascular and Nonexudative AMD Models. Ophthalmology and therapy 13 (8) (2024)